论文部分内容阅读
目的:探讨补中益气汤联合化疗治疗结肠癌手术后的临床疗效。方法:选取36例结肠癌术后患者,随机分为对照组16例和观察组20例,对照组采用化疗的方法治疗,观察组患者在对照组基础上加用补中益气汤进行治疗,观察两组患者的治疗情况,从患者化疗之日开始到死亡结束,统计患者的平均生存时间以及1年生存率、2年生存率、3年生存率。结果:观察组患者的平均生存时间为445天,明显长于对照组的353天,两组平均生存时间比较差异有统计学意义(P<0.05);观察组1年生存率、2年生存率、3年生存率均高于对照组,差异均有统计学意义(P<0.05)。结论:补中益气汤联合化疗治疗结肠癌手术患者,能有效改善患者症状,延长生存时间,提高生存质量,且安全性好,值得临床推广应用。
Objective: To investigate the clinical efficacy of Buzhong Yiqi Decoction combined with chemotherapy in the treatment of colon cancer. Methods: Thirty-six patients with postoperative colon cancer were selected and randomly divided into control group (n = 16) and observation group (n = 20). The control group was treated with chemotherapy. The observation group was treated with Buzhongyiqi Decoction on the basis of control group. The two groups of patients were observed from the day of chemotherapy to the end of death, the average survival time of patients and 1-year survival rate, 2-year survival rate, 3-year survival rate. Results: The average survival time of the observation group was 445 days, which was significantly longer than that of the control group (353 days). The mean survival time of the two groups was statistically significant (P <0.05). The 1-year survival rate, 2-year survival rate, 3-year survival rates were higher than the control group, the difference was statistically significant (P <0.05). Conclusion: Buzhong Yiqi Decoction combined with chemotherapy for patients with colon cancer surgery can effectively improve the symptoms, prolong the survival time and improve the quality of life, and it is safe and worthy of clinical application.